$DMLP
DORCHESTER MINERALS, L.P.

2024 Q4 Form 10-Q Financial Statement

#000143774924032791 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $53.47M
YoY Change 25.54%
Cost Of Revenue $4.135M
YoY Change 11.46%
Gross Profit $49.34M
YoY Change 26.9%
Gross Profit Margin 92.27%
Selling, General & Admin $2.883M
YoY Change 2.96%
% of Gross Profit 5.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.04M
YoY Change 51.7%
% of Gross Profit 20.35%
Operating Expenses $12.92M
YoY Change 37.2%
Operating Profit $36.41M
YoY Change 23.6%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $36.41M
YoY Change 23.6%
Income Tax
% Of Pretax Income
Net Earnings $36.41M
YoY Change 23.59%
Net Earnings / Revenue 68.1%
Basic Earnings Per Share $0.87
Diluted Earnings Per Share $0.87
COMMON SHARES
Basic Shares Outstanding 47.34M 40.09M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.47M
YoY Change 29.81%
Cash & Equivalents $56.47M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $21.82M
Other Receivables $7.659M
Total Short-Term Assets $85.95M
YoY Change 36.19%
LONG-TERM ASSETS
Property, Plant & Equipment $317.4M
YoY Change 145.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $317.4M
YoY Change 145.71%
TOTAL ASSETS
Total Short-Term Assets $85.95M
Total Long-Term Assets $317.4M
Total Assets $403.4M
YoY Change 109.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.782M
YoY Change -22.91%
Accrued Expenses $265.0K
YoY Change -11.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.047M
YoY Change -21.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $842.0K
YoY Change -23.45%
Total Long-Term Liabilities $842.0K
YoY Change -23.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.047M
Total Long-Term Liabilities $842.0K
Total Liabilities $6.889M
YoY Change -22.15%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $396.5M
YoY Change
Total Liabilities & Shareholders Equity $403.4M
YoY Change 109.77%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $36.41M
YoY Change 23.59%
Depreciation, Depletion And Amortization $10.04M
YoY Change 51.7%
Cash From Operating Activities $43.72M
YoY Change 29.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $6.706M
YoY Change 347.07%
Cash From Investing Activities $6.706M
YoY Change 347.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.12M
YoY Change 7.45%
NET CHANGE
Cash From Operating Activities 43.72M
Cash From Investing Activities 6.706M
Cash From Financing Activities -29.12M
Net Change In Cash 21.31M
YoY Change 159.84%
FREE CASH FLOW
Cash From Operating Activities $43.72M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
Dorchester Minerals, L.P.
dei Entity Central Index Key
EntityCentralIndexKey
0001172358
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
47340000
CY2023Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
39583000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-50175
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-0551518
dei Entity Address Address Line1
EntityAddressAddressLine1
3838 Oak Lawn Avenue, Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75219
dei City Area Code
CityAreaCode
214
dei Local Phone Number
LocalPhoneNumber
559-0300
dei Security12b Title
Security12bTitle
Common Units Representing Limited Partnership Interest
dei Trading Symbol
TradingSymbol
DMLP
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47339756
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56468000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47025000 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
21823000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
14407000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
85950000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
69707000 usd
CY2024Q3 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
727863000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
507057000 usd
CY2024Q3 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
411497000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Depletion
OilAndGasPropertyFullCostMethodDepletion
386939000 usd
CY2024Q3 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
316366000 usd
CY2023Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
120118000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
630000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
765000 usd
CY2024Q3 us-gaap Assets
Assets
403352000 usd
CY2023Q4 us-gaap Assets
Assets
191065000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5782000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4195000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
265000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
272000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6047000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4467000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
842000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1041000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
6889000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5508000 usd
CY2024Q3 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
-766000 usd
CY2023Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
113000 usd
CY2024Q3 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
397229000 usd
CY2023Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
185444000 usd
CY2024Q3 us-gaap Partners Capital
PartnersCapital
396463000 usd
CY2023Q4 us-gaap Partners Capital
PartnersCapital
185557000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
403352000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
191065000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
53472000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42594000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
121811000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
113380000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4135000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3714000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10273000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9186000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10041000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6619000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24627000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18597000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2883000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2798000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8703000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8260000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
17059000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
13131000 usd
us-gaap Costs And Expenses
CostsAndExpenses
43603000 usd
us-gaap Costs And Expenses
CostsAndExpenses
36043000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
36413000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29463000 usd
us-gaap Net Income Loss
NetIncomeLoss
78208000 usd
us-gaap Net Income Loss
NetIncomeLoss
77337000 usd
CY2024Q3 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1273000 usd
CY2023Q3 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
1029000 usd
us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
2704000 usd
us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
2445000 usd
CY2024Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
35140000 usd
CY2023Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
28434000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
75504000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
74892000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40167000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38792000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39954000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38514000
CY2023Q2 us-gaap Partners Capital
PartnersCapital
145332000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
29463000 usd
CY2023Q3 us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
35777000 usd
CY2023Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
27134000 usd
CY2023Q3 us-gaap Partners Capital
PartnersCapital
183438000 usd
CY2024Q2 us-gaap Partners Capital
PartnersCapital
170546000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
36413000 usd
CY2024Q3 us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
218622000 usd
CY2024Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
29118000 usd
CY2024Q3 us-gaap Partners Capital
PartnersCapital
396463000 usd
CY2022Q4 us-gaap Partners Capital
PartnersCapital
171518000 usd
us-gaap Net Income Loss
NetIncomeLoss
77337000 usd
us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
35777000 usd
us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
101194000 usd
CY2023Q3 us-gaap Partners Capital
PartnersCapital
183438000 usd
CY2023Q4 us-gaap Partners Capital
PartnersCapital
185557000 usd
us-gaap Net Income Loss
NetIncomeLoss
78208000 usd
us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
235663000 usd
us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
102965000 usd
CY2024Q3 us-gaap Partners Capital
PartnersCapital
396463000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101107000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
101926000 usd
dmlp Asset Acquisition Consideration Transferred Royalty And Mineral Revenue Received
AssetAcquisitionConsiderationTransferredRoyaltyAndMineralRevenueReceived
11301000 usd
dmlp Asset Acquisition Consideration Transferred Royalty And Mineral Revenue Received
AssetAcquisitionConsiderationTransferredRoyaltyAndMineralRevenueReceived
2006000 usd
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
102965000 usd
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
101194000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9443000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2738000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47025000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40754000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56468000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43492000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
235663000 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
35777000 usd
CY2024Q3 dmlp Number Of Counties In Which Entity Operates
NumberOfCountiesInWhichEntityOperates
594 pure
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
28 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Partnership evaluates these estimates on an ongoing basis, using historical experience, consultation with experts and other methods the Partnership considers reasonable in each circumstance. Any effects on the Partnership’s business, financial position, or results of operations resulting from revisions to these estimates are recorded in the period in which the facts that give rise to the revision become known. Although the Partnership believes these estimates are reasonable, actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2024Q3 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.995785

Files In Submission

Name View Source Status
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
0001437749-24-032791-index-headers.html Edgar Link pending
0001437749-24-032791-index.html Edgar Link pending
0001437749-24-032791.txt Edgar Link pending
0001437749-24-032791-xbrl.zip Edgar Link pending
dmlp-20240930.xsd Edgar Link pending
dmlp20240930_10q.htm Edgar Link pending
ex_719191.htm Edgar Link pending
ex_719192.htm Edgar Link pending
ex_719193.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
dmlp-20240930_cal.xml Edgar Link unprocessable
dmlp-20240930_def.xml Edgar Link unprocessable
dmlp-20240930_lab.xml Edgar Link unprocessable
dmlp-20240930_pre.xml Edgar Link unprocessable
dmlp20240930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
0001437749-24-032791-index-headers.html Edgar Link pending
0001437749-24-032791-index.html Edgar Link pending
0001437749-24-032791.txt Edgar Link pending
0001437749-24-032791-xbrl.zip Edgar Link pending
dmlp-20240930.xsd Edgar Link pending
dmlp20240930_10q.htm Edgar Link pending
ex_719191.htm Edgar Link pending
ex_719192.htm Edgar Link pending
ex_719193.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dmlp-20240930_cal.xml Edgar Link unprocessable
dmlp-20240930_def.xml Edgar Link unprocessable
dmlp-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dmlp20240930_10q_htm.xml Edgar Link completed
dmlp-20240930_pre.xml Edgar Link unprocessable